| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
2,798 |
2,466 |
$116K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
3,938 |
3,450 |
$90K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
1,433 |
1,317 |
$71K |
| 84443 |
Thyroid stimulating hormone (TSH) |
2,297 |
2,223 |
$38K |
| 80053 |
Comprehensive metabolic panel |
2,939 |
2,807 |
$31K |
| 80061 |
Lipid panel |
2,267 |
2,193 |
$30K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
3,636 |
3,292 |
$27K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,423 |
712 |
$16K |
| 86738 |
|
922 |
888 |
$14K |
| 86328 |
|
626 |
589 |
$12K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
964 |
933 |
$10K |
| 81000 |
|
3,020 |
2,835 |
$9K |
| 36415 |
Collection of venous blood by venipuncture |
870 |
806 |
$6K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
162 |
156 |
$5K |
| 85027 |
|
589 |
563 |
$4K |
| 84436 |
|
427 |
416 |
$3K |
| 84479 |
|
406 |
395 |
$3K |
| 82274 |
|
57 |
55 |
$967.65 |
| 86701 |
|
96 |
91 |
$912.13 |
| 87088 |
|
65 |
65 |
$561.95 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
65 |
65 |
$557.17 |
| 82043 |
|
83 |
82 |
$505.19 |
| 84153 |
|
27 |
27 |
$495.42 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
13 |
13 |
$467.37 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
12 |
12 |
$436.89 |
| 84439 |
|
33 |
32 |
$316.03 |
| 86592 |
|
60 |
56 |
$271.72 |
| 82570 |
|
25 |
25 |
$135.96 |